Kiffik Biomedical and Rubix LS Partner to Revolutionize Cancer Diagnostics With Interstitial Fluid and Aptamer Technologies
PROVIDENCE, RI / ACCESS Newswire / March 20, 2025 / Kiffik Biomedical, a leader in interstitial fluid (ISF)-based diagnostics ...
Hosted on MSN2mon
Novel screening tech enhances identification of cancer-targeting T cell receptors
Researchers at Children's Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania have developed a new screening technology, Aptamer-based T ...
Researchers develop rapid test to detect dopamine
This sensor may serve as a low-cost and efficient screening tool for various neurological ... this UCF-developed device uses ...
360Dx2d
Kiffik Biomedical, Rubix LS Partner on Colorectal Cancer Test Development
The New England-based firms said that they are developing a rapid at-home test that will be used to detect cancer biomarkers in interstitial fluid samples.
Sacramento Bee3d
Kiffik Biomedical and Rubix LS Partner to Revolutionize Cancer Diagnostics With Interstitial Fluid and Aptamer Technologies
By leveraging ISF-based biomarker detection and aptamer precision technology, KIFFIK and Rubix LS aim to deliver a faster, more accessible, and patient-friendly screening solution that removes ...